Dehydroepiandrosterone inhibits the expression of carcinogen-activating enzymes in vivo

International Journal of Cancer

Volumn 105, Issue 3, 2003, Pages 321-325

  Ciolino, Henry ^a   MacDonald, Chistopher ^a   Memon, Omar ^a   Dankwah, Maame ^a   Yeh, Grace Chao ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cytochrome P450 1A1 1A2; DHEA; DMBA; EROD

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIMETHYLBENZ[A]ANTHRACENE; ETHOXYRESORUFIN DEETHYLASE; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER PREVENTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HORMONAL REGULATION; HORMONE ACTION; IN VIVO STUDY; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTICARCINOGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; BODY WEIGHT; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICROSOMES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0038219969     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11075     Document Type: Article

References (22)

1. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W. Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 1994;131:99-104.
2. Rose DP, Stauber P, Thiel A, Crowley JJ, Milbrath JR. Plasma dehydroepiandrosterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer. Eur J Cancer 1977;13:43-7.
3. Regelson W, Kalimi M. Dehydroepiandrosterone (DHEA) - the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann NY Acad Sci 1994;719:564-75.
4. Luo S, Labrie C, Belanger A, Labrie F. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene - induced mammary carcinoma in the rat. Endocrinology 1997;138:3387-94.
5. McCormick DL, Rao KV, Johnson WD, Bowman-Gram TA, Steele VE, Lubet RA, Kellof GJ. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res 1997;56:1724-6.
6. Schrenk D. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem Pharmacol 1998;55:1155-62.
7. Schwartz AG, Fairman DK, Polansky M, Lewbart ML, Pashko LL. Inhibition of 7,12-dimethylbenz[a]anthracene-initiated and 12-O-tetradecanoyl-phorbol-13-acetate-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Carcinogenesis 1989:10:1809-13.
8. Kim SH, Han HM, Kang SY, Jung KK, Kim TG, Oh HY, Lee YK, Rheu HM. Modulation of chemical carcinogen-induced unscheduled DNA synthesis by dehydroepiandrosterone (DHEA) in the primary rat hepatocytes. Arch Pharm Res 1999;22:474-8.
9. Ikegwuonu FI, Jefcoate CR. Evidence for the involvement of the fatty acid and peroxisomal beta-oxidation pathways in the inhibition by dehydroepiandrosterone (DHEA) and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benz(a)anthracene (BA) of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblasts (C3H10T1/2 cells). Mol Cell Biochem 1999;198:89-100.
10. Prasanna HR, Hart RW, Magee PN. Differential effects of dehydroepiandrosterone and clofibrate on the binding of 7,12-dimethylbenz(a)anthracene to hepatic DNA in vivo - a preliminary study. Drug Chem Toxicol 1989;12:327-35.
11. Pashko LL, Schwartz AG. Effect of food restriction, dehydroepiandrosterone, or obesity on the binding of 3H-7,12-dimethylbenz(a)anthracene to mouse skin DNA. J Gerontol 1983;38:8-12.
12. MacDonald CJ, Ciolino HP, Yeh GC. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1. Cancer Res 2001;61:3919-24.
13. Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW, Sutter TR. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 1999;154:279-86.
14. Schwartz AG, Pashko LL. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. J Cell Biochem 1995;22:210-7.
15. Perkins SN, Hursting SD, Haines DC, James SJ, Miller BJ, Phang JM. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16-α-fluoro-5-androsten-17-one. Carcinogenesis 1997;18:989-94.
16. Casazza JP, Schaffer WT, Veech RL. The effect of dehydroepiandrosterone on liver metabolites. J Nutr 1986;116:304-10.
17. Cleary MP. Effect of dehydroepiandrosterone treatment on liver metabolism in rats. Int J Biochem 1990;22:205-10.
18. Hursting SD, Perkins SN, Haines DC, Ward JM, Phang JM. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res 1995;55:3949-53.
19. Alex S, Braverman LE, Fang SL, Norvell B, Robinson S, Franz C, Longcope C. Dehydroepiandrosterone sulfate does not prevent spontaneous and iodine-induced lymphocytic thyroiditis and diabetes mellitus in the BB/Wor rat. Eur J Endocrinol 1998;138:719-23.
20. Callies F, Arlt W, Siekmann L, Hubler D, Bidlingmaler F, Allolio B. Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females. Steroids 2000;65:98-102.
21. Schwartz AG, Perantoni A. Protective effect of dehydroepiandrosterone against aflatoxin B1- and 7,12-dimethylbenz(a)anthracene-induced cytotoxicity and transformation in cultured cells. Cancer Res 1975;5:2482-7.
22. Ciolino HP, Yeh GC. The steroid hormone dehydroepiandrosterone inhibits CYP1A1 expression in vitro by a post-transcriptional mechanism. J Biol Chem 1999;274:35186-90.